Short description
Empyrean is using genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Tom Henley